IDEX Biometrics receives UK patent grant for on-card remote enrollment
Oslo, Norway, 9 October 2019: IDEX Biometrics ASA, the leading provider of advanced fingerprint identification and authentication solutions, has been granted a patent by the UK Intellectual Property Office for unconnected on-card enrollment on biometric smart cards.
This patent is in the same patent family as enrollment patents granted to IDEX Biometrics by the United States Patent and Trademark office and IP Australia earlier this year. IDEX Biometrics also has patents pending for this innovation in other major territories, in addition to its large portfolio of patents and applications covering its world-leading fingerprint sensor and biometric algorithm technology.
Stan Swearingen, CEO of IDEX Biometrics, commented, “The UK is a strategically important market for biometric smart cards and recent high-profile bank pilots in the country substantiate that remote enrollment is crucial for mass deployment. Our unconnected on-card enrollment solution provides the ability to enroll a fingerprint in a simple, secure and convenient way. We are confident that it is becoming the industry standard.”
A demonstration of IDEX’s remote enrollment solution is available here.
For further information contact:
Stuart Hunt, Head of Investor Relations & Communications
+44 (0)1276 534 632
Anne McAleer, Director, Intellectual Property
+44 (0)7900 279 473
About IDEX Biometrics
IDEX Biometrics ASA (OSE: IDEX) is the leading provider of fingerprint identification technologies offering simple, secure and personal authentication for all. We help people make payments, prove their identity, gain access to information, unlock devices or gain admittance to buildings with the touch of a finger. We invent, engineer and commercialize these secure, yet incredibly user-friendly solutions. Our total addressable market represents a fast-growing multi-billion-unit opportunity.
For more information, visit www.idexbiometrics.com and follow @IDEXBiometrics
This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.